TCL Archive DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported November 17, 1978
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER March 20, 1992
